216 related articles for article (PubMed ID: 18443309)
1. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.
Pack AM; Morrell MJ; Randall A; McMahon DJ; Shane E
Neurology; 2008 Apr; 70(18):1586-93. PubMed ID: 18443309
[TBL] [Abstract][Full Text] [Related]
2. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.
Pack AM; Morrell MJ; Marcus R; Holloway L; Flaster E; Doñe S; Randall A; Seale C; Shane E
Ann Neurol; 2005 Feb; 57(2):252-7. PubMed ID: 15668966
[TBL] [Abstract][Full Text] [Related]
3. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI
Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779
[TBL] [Abstract][Full Text] [Related]
4. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy.
Kim SH; Lee JW; Choi KG; Chung HW; Lee HW
Epilepsy Behav; 2007 Mar; 10(2):291-5. PubMed ID: 17224308
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
[TBL] [Abstract][Full Text] [Related]
7. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
Guo CY; Ronen GM; Atkinson SA
Epilepsia; 2001 Sep; 42(9):1141-7. PubMed ID: 11580761
[TBL] [Abstract][Full Text] [Related]
8. Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs.
Pack AM; Morrell MJ; McMahon DJ; Shane E
Epilepsy Behav; 2011 Aug; 21(4):453-8. PubMed ID: 21704565
[TBL] [Abstract][Full Text] [Related]
9. Effect of switching hepatic enzyme-inducer antiepileptic drug to levetiracetam on bone mineral density, 25 hydroxyvitamin D, and parathyroid hormone in young adult patients with epilepsy.
Phabphal K; Geater A; Limapichat K; Sathirapanya P; Setthawatcharawanich S; Leelawattana R
Epilepsia; 2013 Jun; 54(6):e94-8. PubMed ID: 23586623
[TBL] [Abstract][Full Text] [Related]
10. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813
[TBL] [Abstract][Full Text] [Related]
11. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
[TBL] [Abstract][Full Text] [Related]
12. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
Serin HM; Koç ZP; Temelli B; Esen İ
Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
[TBL] [Abstract][Full Text] [Related]
13. Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study.
Lai EC; Hsieh CY; Su CC; Yang YK; Huang CW; Lin SJ; Setoguchi S
Medicine (Baltimore); 2016 Aug; 95(35):e4481. PubMed ID: 27583857
[TBL] [Abstract][Full Text] [Related]
14. Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: The NEAD prospective observational study.
Cohen MJ; Meador KJ; May R; Loblein H; Conrad T; Baker GA; Bromley RL; Clayton-Smith J; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
Epilepsy Behav; 2019 Mar; 92():154-164. PubMed ID: 30660966
[TBL] [Abstract][Full Text] [Related]
15. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
Kaminow L; Schimschock JR; Hammer AE; Vuong A
Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients.
El-Haggar SM; Mostafa TM; Allah HMS; Akef GH
Arq Neuropsiquiatr; 2018 Jul; 76(7):452-458. PubMed ID: 30066796
[TBL] [Abstract][Full Text] [Related]
17. The association between BsmI polymorphism and bone mineral density in young patients with epilepsy who are taking phenytoin.
Phabphal K; Geater A; Limapichart K; Sathirapanya P; Setthawatcharawanich S; Witeerungrot N; Thammakumpee N; Leelawattana R
Epilepsia; 2013 Feb; 54(2):249-55. PubMed ID: 23281616
[TBL] [Abstract][Full Text] [Related]
18. Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
Koo DL; Hwang KJ; Han SW; Kim JY; Joo EY; Shin WC; Lee HW; Seo DW; Hong SB
Epilepsy Res; 2014 Mar; 108(3):442-7. PubMed ID: 24507862
[TBL] [Abstract][Full Text] [Related]
19. Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a prospective study.
Krishnamoorthy G; Nair R; Sundar U; Kini P; Shrivastava M
Neurol India; 2010; 58(2):213-9. PubMed ID: 20508338
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy.
Tsukahara H; Kimura K; Todoroki Y; Ohshima Y; Hiraoka M; Shigematsu Y; Tsukahara Y; Miura M; Mayumi M
Pediatr Int; 2002 Jun; 44(3):247-53. PubMed ID: 11982890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
